This is crucial for injury recovery because new blood vessels deliver oxygen and nutrients to the affected areas, promoting faster healing
Safety: what we know, what we dont What clinical trial safety reviews suggest The clinical safety review literature reports several reassuring signals: No meaningful increase in IGF-1 in monitored long-term studies (jofem.org) No clear negative effect on carbohydrate metabolism in testing described (contrast with full hGH) (jofem.org) No clear immunogenicity signal (e.g., anti-AOD antibodies) in the subset assessed in those trials (jofem.org) The major limitation: long-term real-world certainty is thin The problem with many peptides is not that everything is dangerousits that the certainty level is often lower than patients assume
Explored in adipose tissue and energy balance research
A standard 250 mcg dose draws to 7.5 units on an insulin syringe
These benefits allow for more consistent training, fewer setbacks from injury, and a body that is better positioned to respond to exercise over time
Any therapies, consultations, or prescriptions are provided only following assessment by a licensed physician and where clinically appropriate
